⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21338941 | 0.89 | — | — | |
| SCHEMBL21338942 | 0.86 | — | — | |
| SCHEMBL23547122 | 0.78 | — | — | |
| SCHEMBL23046600 | 0.77 | — | — | |
| SCHEMBL18763270 | 0.76 | — | — | |
| SCHEMBL25808865 | 0.72 | — | — | |
| SCHEMBL19413141 | 0.72 | — | — | |
| SCHEMBL21677103 | 0.71 | — | — | |
| SCHEMBL21016677 | 0.71 | — | — | |
| SCHEMBL14463061 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10933038-B2 | Use of (benzenesulfonamido) benzamide compounds for inhibiting liver fibrosis | Hebei Medfaith Pharmaceutical Technology Co., Ltd. (CN) | 2021-03-02 | — | — | US | disclosed |